Twice a day, 7-year-old Hannah Austin exhales all the air from her lungs. She then takes a puff of a low-dose steroid from a purple inhaler, holds her breath for a few seconds and exhales.
FDA panelists this week will scrutinize the safety of certain drugs approved for children - including anti-viral and anti-asthma drugs from Glaxo, Roche and Novartis - in meetings that could have wider implications for the industry.
Use your body's natural rhythms -- and a few tips from the experts -- to find the best time of day to work out, see a doctor, go to the post office, and more.
Sepracor Inc .posted lower-than-expected results Friday and cut its 2007 outlook amid competition for its insomnia drug and reduced reimbursement for its asthma drug, sending its shares down 20 percent.
The British drugmaker GlaxoSmithKline is trying wean just a little more revenue from its top-selling blockbuster Advair, and its ability to do so depends on whether FDA experts believe the allergy drug merits a larger patient population.
Allergy season is in full swing and, in the $25 billion market for respiratory drugs, GlaxoSmithKline is likely to hold its throne as the asthma king for this season and years to come, despite growing competition.
Once again the thorny issue of replacement estrogen grabbed attention in the major medical journals -- the latest in a seemingly never-ending string of studies that document the pluses and risks of this hormone.
An FDA advisory committee voted to take away over-the-counter status for asthma inhalers that use the chemical epinephrine and an ozone-depleting propellant on Tuesday, but the vote is not a final decision.
Twice a day, 7-year-old Hannah Austin exhales all the air from her lungs. She then takes a puff of a low-dose steroid from a purple inhaler, holds her breath for a few seconds and exhales.
FDA panelists this week will scrutinize the safety of certain drugs approved for children - including anti-viral and anti-asthma drugs from Glaxo, Roche and Novartis - in meetings that could have wider implications for the industry.
Use your body's natural rhythms -- and a few tips from the experts -- to find the best time of day to work out, see a doctor, go to the post office, and more.
Sepracor Inc .posted lower-than-expected results Friday and cut its 2007 outlook amid competition for its insomnia drug and reduced reimbursement for its asthma drug, sending its shares down 20 percent.
The British drugmaker GlaxoSmithKline is trying wean just a little more revenue from its top-selling blockbuster Advair, and its ability to do so depends on whether FDA experts believe the allergy drug merits a larger patient population.
Allergy season is in full swing and, in the $25 billion market for respiratory drugs, GlaxoSmithKline is likely to hold its throne as the asthma king for this season and years to come, despite growing competition.
Once again the thorny issue of replacement estrogen grabbed attention in the major medical journals -- the latest in a seemingly never-ending string of studies that document the pluses and risks of this hormone.
An FDA advisory committee voted to take away over-the-counter status for asthma inhalers that use the chemical epinephrine and an ozone-depleting propellant on Tuesday, but the vote is not a final decision.
A few months ago, I was interviewing a principal at a Chicago, Illinois, public elementary school, when from outside her office came the sounds of a child coughing.
Genentech Inc. put a stop to a clinical trial for a potential treatment for peanut allergies after two children suffered "severe" reactions during tests, according to a news report published Monday.
Asthma hits all areas of the United States, but Knoxville, Tennessee, is the worst, according to an organization's ranking of the nation's cities released Tuesday.
In late June, Arthur Levinson was talking with MONEY's Erica Garcia in his corner office in south San Francisco, nervously shaking a sneaker-clad foot while awaiting the decision from the Food and ...
In late June, Arthur Levinson was talking with MONEY's Erica Garcia in his corner office in south San Francisco, nervously shaking a sneaker-clad foot while awaiting the decision from the Food and Drug Administration on Xolair, Genentech's asthma treatment.
In April we called Genentech "the brightest star in the [biotech] sector." Our confidence was vindicated in May, when shares of Genentech (DNA), the second-largest biotech, shot up a whopping 45% i...
At least one pharmaceutical giant is sick and tired of Americans filling prescriptions in Canada, where drugs can sell for 30% to 70% less. On Jan. 21, GlaxoSmithKline, the maker of antidepressant ...
Springtime on the plains of Midland, Texas, is an asthmatic's nightmare. Along with the tumbleweed and dust, there's always too much pollen floating in the wind. Alexis Milmine feels a stirring in ...
Anything that sounds too good to be true usually is, right? So you're probably leery about joining one of those interactive computer networks that promise to launch you over your phone line onto th...
The page you requested cannot be found. The page you are looking for might have been removed, had its name changed, or is temporarily unavailable.
Please try the following:
• If you typed the page address in the Address bar, make sure that it is spelled correctly.
• Open the www.cnn.com home page and look for links to the information you want.
• Use the navigation bar above to find the link you are looking for.
• Click the Back button to try another link.
• Enter a term in the search form below to look for information on CNN sites or the Internet.
Video
